Diligence memo · auto-generated · as of July 2, 2026
Sante Veritas Therapeutics Inc
Sante Veritas Therapeutics Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Sante Veritas Therapeutics Inc operates in Pharma, based in VANCOUVER.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Sante Veritas Therapeutics Inc has raised $267K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $267K on 2017-01-25.
Most recent recorded round closed around 2017-01-25.
Valuation (modeled)modeled
Provath models Sante Veritas Therapeutics Inc at approximately $13M (range $150K–$143M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.90× the median modeled value of Pre-Seed Pharma companies in 2016–2018 (20 peers) — value vs value, same stage and era. Within the normal band (90% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 9.4 yr ago; this sector typically re-raises about every 16 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 23% of Pharma peers (310 compared).
Modeled value ranks above 38% of those peers.
Closest niche peers: vivo-TIL Therapeutics, Inc, JSK Therapeutics, Inc., Kyto Biopharma Inc, Manzara Therapeutics, Inc., Mirata BioPharma, LLC.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.